In today’s litigation landscape, data is both a critical asset and a potential source of risk. Successfully navigating the eDiscovery process requires more than just collecting and reviewing documents ...

Historically, the drug development process can take 10-15 years from the initial discovery phase to regulatory approval. Moreover, the total cost of these endeavors can often run into billions of ...

Generative AI is revolutionizing legal investigations and discovery workflow in ways we never thought possible–until recently. Join us on October 30th at 1 pm ET for a groundbreaking EDRM webinar that ...

EMERYVILLE, Calif., Sept. 27, 2023 /PRNewswire/ -- PhenomeX Inc. (Nasdaq: CELL), a functional cell biology company, announced the Opto® Memory B Discovery Human workflow, further expanding diversity ...

Kostyantyn Volkov is CEO and cofounder of IT Craft, a company specializing in full-cycle software development of any complexity. Remarkably, 90% of all startups shatter. No market need is the top ...

Some say that AI’s potential in drug development is overstated. Others say that it is, if anything, understated. Who is right? Only time will tell. In the meantime, both sides—and the ...